|Mr. Michael James Abbott||Exec. Chairman||793.23k||N/A||N/A|
|Mr. Nicholas Keane Vita||Vice Chairman & CEO||986.32k||N/A||N/A|
|Mr. David J. Hart||Chief Operating Officer||499.24k||N/A||N/A|
|Mr. Jesse Channon||Chief Growth Officer||476.5k||N/A||N/A|
|Dr. Rosemary Mazanet||Chief Scientific Officer||N/A||N/A||1956|
|Mr. Bryan Lamont Olson||Chief People & Admin. Officer||N/A||N/A||N/A|
|Ms. Lee Ann Evans||VP of Investor Relations||N/A||N/A||N/A|
|Kate Driscoll||VP of Compliance||N/A||N/A||N/A|
|Mr. David Sirolly||Chief Legal Officer & Gen. Counsel||N/A||N/A||N/A|
|Mr. Bryant Ison||Chief Marketing Officer||N/A||N/A||N/A|
Columbia Care Inc. cultivates, manufactures, and provides cannabis-based health and wellness solutions, and derivative products. It offers flowers, edibles, oils, and tablets under the Cannabist, Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label Cannabidiol brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of January 3, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Columbia Care Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.